Hopp til innhold
NHI.no
Annonse

Grønn stær, glaukom: Oppfølging

Det er viktig å være klar over at behandlingen for glaukom som regel er livsvarig. Ingen form for behandling vil kunne gi bedre syn, og det kan være bivirkninger forbundet med all slags behandling. Det er nødvendig med regelmessige kontroller hos øyelege for å sikre at behandlingen er tilfredsstillende. Hva som er beste behandling, og hvor ofte kontrollene skal foregå, må avgjøres i hvert enkelt tilfelle.

Annonse

Dette dokumentet er basert på det profesjonelle dokumentet Glaukoma simplex . Referanselisten for dette dokumentet vises nedenfor

  1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004; 363: 1711-20. PubMed
  2. Gupta D. Glaucoma. Am Fam Physician. 2016 Apr 15;93(8):668-674.
  3. Bek T, et al. Simplex glaucom. Lægehåndbogen, sist oppdatert 25.04.2019.
  4. Jenssen F, Krefting E, Ulvik SO. Åpenvinkel glaukom. Norsk kvalitetshåndbok for oftalmologi, 2015. www.helsebiblioteket.no
  5. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267.
  6. Tham Y-C, Li X, Wong TY, et al. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophtalmology, Nov 2014; 121 (11) : 2081–2090 . pmid:10.1016/j.ophtha.2014.05.013
  7. Bell JA. Primary open-angle glaucoma. Medscape, last updated Feb 20, 2014. emedicine.medscape.com
  8. Bourne RR, Jonas JB, Flaxman, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophtalmol 2014. pmid:24665132 PubMed
  9. McKinnen SJ. Glaucoma: ocular Alzheimer's disease?. Front Biosci 2003; 8: 1140-56. PubMed
  10. Kang JH, Boumenna T, Stein JD, et al. Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma. JAMA Ophtalmlol 2019. pmid:31046067 PubMed
  11. Zhao D, Cho J, Kim MH, et al. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology. 2015 ;122(1):72-8. doi: 10.1016/j.ophtha.2014.07.051.
  12. Weinreb RN, Bowd C, Zangwill LM. Glaucoma detection using scanning laser polarimetry with variable corneal polarization compensation. Arch Ophthalmol 2003; 121: 218-24. PubMed
  13. Kumar S, Giubilato A, Morgan W, et al. Glaucoma screening: analysis of conventional and telemedicine-friendly devices. Clin Experiment Ophthalmol. 2007;35(3):237–243.
  14. Jeong da W, Kook MS, Lee KS, Lee JR, Han S. Circadian pattern of intraocular pressure fluctuations in young myopic eyes with open-angle glaucoma. Invest Ophthalmol Vis Sci. 2014;55(4):2148–2156.
  15. Moyer VA, et al. Screening for glaucoma: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013. doi:10.7326/0003-4819-159-6-201309170-00685 DOI
  16. Khaw PT, Shah P, Elkington AR. Glaucoma - 1. Diagnosis. BMJ 2004; 328: 97-9. PubMed
  17. Kuang TM, Zhang C, Zangwill LM, et al. Estimating the lead time gained by optical coherence tomography in detecting glaucoma before development of visual field defects. Ophtalmology. Published Online: July 18, 2015 . doi:http://dx.doi.org/10.1016/j.ophtha.2015.06.015
  18. Springelkamp H, Lee K, Wolfs RC, et al. Population-based evaluation of retinal nerve fiber layer, retinal ganglion cell layer, and inner plexiform layer as a diagnostic tool for glaucoma. Invest Ophthalmol Vis Sci. 2014;55(12):8428–8438.
  19. Shih GC, Calkins DJ. Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action. Expert Rev Ophtalmol 2012; 7: 161-75. PubMed
  20. Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 2005; 331: 134-6. British Medical Journal
  21. Distelhorst JS, Hughes GM. Open-angle glaucoma. Am Fam Physician 2003; 67: 1937-44. PubMed
  22. King A, Migdal C. Clinical management of glaucoma. J R Soc Med 2000;93:175-7. PubMed
  23. Kolko M. Present and New Treatment Strategies in the Management of Glaucoma. Open Ophthalmol J 2015; 9: 89-100. pmid:26069521 PubMed
  24. Khaw PT, Shah P, Elkington AR. Glaucoma - 2: Treatment. BMJ 2004; 328: 156-8. PubMed
  25. Saylor M, McLoon LK, Harrison AR, Lee MS. Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent. Arch Ophtalmol 2009; 127: 402-6. PubMed
  26. Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2014 Dec 18.
  27. Li X, Wang W, Zhang X. Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. BMC Ophthalmology (2015) 15:107 . doi:10.1186/s12886-015-0091-2 DOI
  28. Kirwan JF, Rennie C, Evans JR. Beta radiation for glaucoma surgery. Cochrane Database Syst Rev 2012; 6: CD003433. Cochrane (DOI)
Annonse
Annonse